drugset / Trial / NCT02449616
Evaluation of Repeat Administration of Purified Poloxamer 188
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety of repeat administration of MST-188 during vaso-occlusive crisis of sickle cell disease. Additionally, this study will evaluate the development of acute chest syndrome during VOC and re-hospitalization for recurrence of VOC.
Timeline
- Start
- 2015-06
- Primary completion
- 2016-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vepoloxamer | Small molecule | 30 mg/kg | Intravenous |